“Lenacapavir is not permission for promiscuity or reckless living,” she said.
The Ebonyi government has officially launched the injectable pre–exposure prophylaxis, lenacapavir, for HIV prevention.
Ms Ngon said that building a skilled and competent workforce was essential for delivering effective HIV prevention services nationwide.
WHO in 2025 recommended the use of injectable lenacapavir twice a year as an additional pre-exposure prophylaxis option for HIV prevention.
WHO says it has supported nine countries to begin rolling out lenacapavir, a long-acting HIV prevention medicine.
The federal government has secured a price reduction of the twice-yearly HIV prevention injection, lenacapavir, from $28,000 to just $40 per person.
Mr Ghebreyesus stated, “In 2024, 60 countries experienced significant measles outbreaks, nearly double the number in 2022.’’
Around 630,000 people died from HIV-related causes that year, while 31.6 million were on antiretroviral treatment, up from 30.3 million in 2023.
